Organization
Isomorphic Labs
Alphabet AI drug-discovery company led by Demis Hassabis
- Score
- 0%
- 95% interval
- 0%–79%
- Resolved
- 1
- Record (C–P–W)
- 0–0–1
- Open
- 1
- Too vague
- 0
Not ranked yet: leaderboards need at least 5 resolved claims (has 1). Score = specificity-weighted average of claim points; we grade claims, not people.
Promise tracker
Kept 0 Partly 0 Broken 1 Pending 1
Calibration
No resolved claims with a stated probability yet, so there is nothing to calibrate. Calibration needs forecasts like “70% chance of X”.
Track record
Resolved (1)
BrokenPromise
AI-designed drugs in clinical trials by the end of 2025
“Hassabis had said last year the company would have AI-designed drugs in clinical trials by the end of 2025.”
Open (1)
PendingPromise
First clinical trials of its AI-designed drugs by end of 2026
“Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday…”
Embed this scorecard
Right of reply: send a correction or response.